Table I.
Clinical features and metabolic characteristics for healthy women (control group) and PCOS women (study group).
|
Study group
(n=30) |
Control group
(n=30) |
p-value | |
|---|---|---|---|
| Age (years) | 26.80 ± 0.67 | 25.10 ± 0.89 | 0.73 |
| BMI (kg/m2) | 24.60 ± 0.90 | 23.60 ± 1.10 | 0.44 |
| TAOS (mmol/L) | 1.25 ± 0.02 | 2.13 ± 0.10 | 0.03 |
| Waist size (cm) | 82.20 ± 1.50 | 81.50 ± 1.20 | 0.84 |
| Waist/hip ratio | 0.81 ± 0.02 | 0.79 ± 0.01 | 0.22 |
| Total cholesterol (mg/dL) | 172.65 ± 1.10 | 174.20 ± 1.0 | 0.67 |
| Triglyceride (mg/dl) | 156.30 ± 12.90 | 148.40 ± 10.30 | 0.73 |
| LDL-C (mg/dl) | 105.50 ± 8.20 | 96.30 ± 6.70 | 0.32 |
| HDL-C (mg/dl) | 42.30 ± 3.50 | 56.20 ± 6.30 | 0.04 |
| Fasting insulin (mIU/min/mL) | 17.10 ± 6.10 | 10.20± 3.40 | 0.01 |
| Fasting glucose (mg/dL) | 86.30 ± 1.10 | 84.90 ± 0.20 | 0.64 |
| HOMA index | 3.10 ± 1.10 | 1.70 ± 0.60 | 0.04 |
| Hcy (mmol/L) | 12.80± 1.70 | 9.30± 1.70 | 0.001 |
| CRP (mg/dL) | 4.90 ± 0.71 | 1.50 ± 0.69 | 0.04 |
| LH/FSH ratio | 4.63 ± 1.02 | 2.78 ± 0.98 | 0.04 |
| FSH (mIU/ml) | 4.24 ± 0.52 | 4.62 ± 0.42 | 0.23 |
| LH (mIU/ml) | 19.63 ± 3.20 | 12.84 ± 2.10 | 0.04 |
Data are shown as mean±SD, and analyzed by student’s t test.
BMI: body mass index,
TAOS: total antioxidant status,
LDL: low-density lipoprotein,
HDL: high-density lipoprotein HOMA: homeostasis model assessment,
Hcy: homocysteine,
CRP: C-reactive protein,
FSH: follicle-stimulating hormone
LH: luteinizing hormone